Minimally Invasive and Robotic Surgery for Breast Cancer

Breast cancer is the most common cancer diagnosed in women and the second most common cause of death from cancer among women worldwide. The minimally invasive mastectomy has demonstrated several potential benefits including enhanced visualization and improved patient reported satisfaction while maintaining peri-operative and oncological outcomes comparable to open procedures. The rNSM has shown to be a safe and feasible approach in appropriately selected patients however further studies are needed to validate its long-term oncologic safety.